Telo Genomics Corp (TELO) — Cash Flow-to-Debt Ratio
Telo Genomics Corp (TELO) has a Cash Flow-to-Debt Ratio of -0.47x as of September 2025, meaning its operating cash flow of CA$-300.71K could theoretically repay 0% of its total liabilities (CA$633.60K) in one year. See Telo Genomics Corp (TELO) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Telo Genomics Corp Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Telo Genomics Corp across 13 annual periods. Also explore Telo Genomics Corp annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Telo Genomics Corp (2013–2025)
Year-by-year debt coverage analysis for Telo Genomics Corp. For market capitalisation and broader financial context, see Telo Genomics Corp market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.88x | CA$-2.33 Million | CA$396.32K | ▲ +10.3% |
| 2024 | -6.55x | CA$-2.46 Million | CA$375.59K | ▲ +22.1% |
| 2023 | -8.40x | CA$-2.63 Million | CA$312.87K | ▼ -7.7% |
| 2022 | -7.80x | CA$-1.79 Million | CA$230.07K | ▼ -8.5% |
| 2021 | -7.19x | CA$-1.10 Million | CA$153.66K | ▼ -152.6% |
| 2020 | -2.85x | CA$-1.12 Million | CA$393.42K | ▼ -1035.0% |
| 2019 | -0.25x | CA$-327.84K | CA$1.31 Million | ▲ +94.2% |
| 2018 | -4.31x | CA$-3.21 Million | CA$743.53K | ▲ +51.6% |
| 2017 | -8.91x | CA$-7.90 Million | CA$886.25K | ▼ -295.2% |
| 2016 | -2.26x | CA$-78.65K | CA$34.87K | ▲ +65.6% |
| 2015 | -6.55x | CA$-106.77K | CA$16.30K | ▼ -207.6% |
| 2014 | -2.13x | CA$-35.47K | CA$16.66K | ▲ +56.5% |
| 2013 | -4.90x | CA$-66.68K | CA$13.61K | — |